Hormone blocking drugs reduce risk of breast cancer returning

A new study suggests that women who have had breast cancer could benefit from staying on hormone blocking drugs for up to 15 years. Research carried out by US scientists found it cut the risk of cancer coming back by a third.

Experts say the findings could change the way millions of women are treated.

James Gallagher reports.